Literature DB >> 2405495

Oxidative denaturation in congenital hemolytic anemias: the unstable hemoglobins.

C C Winterbourn1.   

Abstract

The unstable Hbs vary in their degree of instability and in their clinical manifestations, with some causing a hemolytic anemia in the heterozygote. The molecular abnormalities result in increased flexibility or conformational distortion that alters the environment of the heme groups. As a result, oxidation to methemoglobin is enhanced and, more importantly, there is also rapid conversion of methemoglobin to hemichrome and sometimes heme loss, with resultant denaturation and precipitation as Heinz bodies. Methemoglobin formation and recycling are accompanied by release of superoxide. Distortion and decreased deformability of the cells due to the presence of Heinz bodies, leading to trapping in the microcirculation, is one likely contributor to red cell destruction; membrane damage caused by excess oxidants released from the unstable Hb is another. However, a prime factor could be hemichrome binding to the cytoplasmic domain of band 3, leading to clustering of band 3 in the membrane and aggregation of the hemichrome as Heinz bodies. This could result in immunologic recognition of the redistributed band 3 by autologous senescent antibodies, leading to removal of the cells from circulation. Hemolytic crises are often precipitated by the administration of redox-active drugs or by infections. One mechanism for this is the enhanced intracellular oxidation of Hb due either to reaction with the drug or with oxidants generated by phagocytic cells in combating the infectious agent. Another factor in infections is pyrexia, since even a small elevation in temperature can cause a marked increase in the rate of conversion of methemoglobin to hemichrome.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2405495

Source DB:  PubMed          Journal:  Semin Hematol        ISSN: 0037-1963            Impact factor:   3.851


  11 in total

1.  Foxo3 is required for the regulation of oxidative stress in erythropoiesis.

Authors:  Dragan Marinkovic; Xin Zhang; Safak Yalcin; Julia P Luciano; Carlo Brugnara; Tara Huber; Saghi Ghaffari
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

2.  Two patients in a family with unstable hemoglobin, Hb Hirosaki: anemia was ameliorated but hemolysis persists after splenectomy.

Authors:  Kenji Shinohara; Yukio Hattori
Journal:  Int J Hematol       Date:  2006-08       Impact factor: 2.490

3.  SOD2 deficiency in hematopoietic cells in mice results in reduced red blood cell deformability and increased heme degradation.

Authors:  Joy G Mohanty; Enika Nagababu; Jeffrey S Friedman; Joseph M Rifkind
Journal:  Exp Hematol       Date:  2012-11-06       Impact factor: 3.084

4.  Abnormal erythroid maturation leads to microcytic anemia in the TSAP6/Steap3 null mouse model.

Authors:  Lionel Blanc; Julien Papoin; Gargi Debnath; Michel Vidal; Robert Amson; Adam Telerman; Xiuli An; Narla Mohandas
Journal:  Am J Hematol       Date:  2015-03       Impact factor: 10.047

5.  Role of the membrane in the formation of heme degradation products in red blood cells.

Authors:  Enika Nagababu; Joy G Mohanty; Surya Bhamidipaty; Graciela R Ostera; Joseph M Rifkind
Journal:  Life Sci       Date:  2009-12-01       Impact factor: 5.037

Review 6.  Pro-inflammatory cytokine-mediated anemia: regarding molecular mechanisms of erythropoiesis.

Authors:  F Morceau; M Dicato; M Diederich
Journal:  Mediators Inflamm       Date:  2010-03-01       Impact factor: 4.711

Review 7.  Oxidative stress in the regulation of normal and neoplastic hematopoiesis.

Authors:  Saghi Ghaffari
Journal:  Antioxid Redox Signal       Date:  2008-11       Impact factor: 8.401

8.  Heme degradation and oxidative stress in murine models for hemoglobinopathies: thalassemia, sickle cell disease and hemoglobin C disease.

Authors:  Enika Nagababu; Mary E Fabry; Ronald L Nagel; Joseph M Rifkind
Journal:  Blood Cells Mol Dis       Date:  2008-02-08       Impact factor: 3.039

9.  Serotonin is a key factor for mouse red blood cell survival.

Authors:  Pascal Amireault; Elisa Bayard; Jean-Marie Launay; David Sibon; Caroline Le Van Kim; Yves Colin; Michel Dy; Olivier Hermine; Francine Côté
Journal:  PLoS One       Date:  2013-12-17       Impact factor: 3.240

10.  Oxidative Profile of Patients with Sickle Cell Disease.

Authors:  Charles Antwi-Boasiako; Gifty B Dankwah; Robert Aryee; Charles Hayfron-Benjamin; Eric S Donkor; Andrew D Campbell
Journal:  Med Sci (Basel)       Date:  2019-01-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.